Stereotaxis to Report Second Quarter Financial Results on August 9, 2022
July 19, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
July 11, 2022 09:08 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark...
Journal of Atrial Fibrillation & Electrophysiology Publishes Special Issue Dedicated to Robotics in EP
June 06, 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 06, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces the publication of a...
Stereotaxis Reports 2022 First Quarter Financial Results
May 10, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Heart Centre Rigshospitalet Copenhagen Celebrates 5,000 Robotic Cardiac Ablation Procedures
May 04, 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 04, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, celebrates the achievements of...
Stereotaxis to Report First Quarter Financial Results on May 10, 2022
April 14, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders
March 24, 2022 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 24, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Poland’s...
Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis
March 09, 2022 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today is holding the grand...
Stereotaxis Reports 2021 Full Year Financial Results
March 03, 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 03, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Present at Upcoming Investor Conferences
February 14, 2022 09:04 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...